EP1555271 - Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.10.2006 Database last updated on 05.07.2024 | Most recent event Tooltip | 20.10.2006 | Application deemed to be withdrawn | published on 22.11.2006 [2006/47] | Applicant(s) | For all designated states Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Im Neuenheimer Feld 280 69120 Heidelberg / DE | [N/P] |
Former [2005/29] | For all designated states Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Im Neuenheimer Feld 280 69120 Heidelberg / DE | Inventor(s) | 01 /
Schadendorf, Dirk Weberstrasse 3 68165 Mannheim / DE | 02 /
Paschen, Annette Weinheimer Strasse 117 68549 Ilvesheim / DE | 03 /
Kropshofer, Harald Hangstrasse 4 79539 Lörrach / DE | [2005/29] | Representative(s) | Schüssler, Andrea Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | [N/P] |
Former [2005/29] | Schüssler, Andrea, Dr. Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | Application number, filing date | 04000772.6 | 15.01.2004 | [2005/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1555271 | Date: | 20.07.2005 | Language: | EN | [2005/29] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 14.01.2005 | Classification | IPC: | C07K14/705, C07K19/00, C07K16/28, C12N15/12, C12N15/63, G01N33/53, G01N33/68, A61K38/17, A61K39/00, A61K39/395 | [2005/29] | CPC: |
C07K14/705 (EP);
A61K38/00 (EP);
A61K39/00 (EP);
C12N2799/021 (EP)
| Designated contracting states | (deleted) [2006/15] |
Former [2005/29] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR | Title | German: | Peptide zur Diagnose und Behandlung von TRP-2+ und/oder TRP-1+ Tumoren | [2005/29] | English: | Peptides useful for diagnosis and therapy of TRP-2+ and/or TRP-1+ tumors | [2005/29] | French: | Peptides utilisés pour le diagnose et traitement des tumeurs TRP-2+ et/ou TRP-1+ | [2005/29] | Examination procedure | 21.01.2006 | Application deemed to be withdrawn, date of legal effect [2006/47] | 21.06.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2006/47] | Fees paid | Penalty fee | Penalty fee Rule 85a EPC 1973 | 28.02.2006 | AT   M01   Not yet paid | 28.02.2006 | BE   M01   Not yet paid | 28.02.2006 | BG   M01   Not yet paid | 28.02.2006 | CH   M01   Not yet paid | 28.02.2006 | CY   M01   Not yet paid | 28.02.2006 | CZ   M01   Not yet paid | 28.02.2006 | DE   M01   Not yet paid | 28.02.2006 | DK   M01   Not yet paid | 28.02.2006 | EE   M01   Not yet paid | 28.02.2006 | ES   M01   Not yet paid | 28.02.2006 | FI   M01   Not yet paid | 28.02.2006 | FR   M01   Not yet paid | 28.02.2006 | GB   M01   Not yet paid | 28.02.2006 | GR   M01   Not yet paid | 28.02.2006 | HU   M01   Not yet paid | 28.02.2006 | IE   M01   Not yet paid | 28.02.2006 | IT   M01   Not yet paid | 28.02.2006 | LU   M01   Not yet paid | 28.02.2006 | MC   M01   Not yet paid | 28.02.2006 | NL   M01   Not yet paid | 28.02.2006 | PT   M01   Not yet paid | 28.02.2006 | RO   M01   Not yet paid | 28.02.2006 | SE   M01   Not yet paid | 28.02.2006 | SI   M01   Not yet paid | 28.02.2006 | SK   M01   Not yet paid | 28.02.2006 | TR   M01   Not yet paid | Penalty fee Rule 85b EPC 1973 | 28.02.2006 | M01   Not yet paid | Additional fee for renewal fee | 31.01.2006 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0127295 (DEUTSCHES KREBSFORSCH [DE], et al) [X] 1-19 * page 1 - page 3; figure 3; examples 3,5 *; | [X]WO0190197 (UNIV AUSTRALIAN [AU], et al) [X] 1-19 * page 89, line 8 - line 13; figure 27; example 3; claims 24-28,56-59 *; | [X]WO02068653 (IMCLONE SYSTEMS INC [US], et al) [X] 1-19 * the entire document, particularly pages 3,7,8,10,13; SEQ ID NO. 15 and the claims *; | [X]WO02074788 (US GOV HEALTH & HUMAN SERV [US], et al) [X] 1-19 * page 3, line 25 - page 5, line 6; examples 6-9; claims 1,5,7,13,14,25,36-51 *; | [X] - UNIPROT, (19981101), Database accession no. O75767, URL: EBI, XP002295233 [X] 1-6 * column A * | [A] - TOULOUKIAN CE ET AL., "Expression of a "Self-"Antigen by Human Tumor Cells Enhances Tumor Antigen-specific CD4+ T-Cell Function", CANCER RESEARCH, (20020915), vol. 62, pages 5144 - 5147, XP002295231 [A] * the whole document * | [A] - DAVILA E ET AL., "Generation of Antitumor Immunity by Cytotoxic T Lymphocyte Epitope Peptide Vaccination, CpG-oligodeoxynucleotide Adjuvant, and CTLA-4 Blockade", CANCER RESEARCH, (20030615), vol. 63, pages 3281 - 3288, XP002295232 [A] * the whole document * | [A] - WANG R-F & WANG HY, Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells, NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, PAGE(S) 149-154, (200202), ISSN 1087-0156, XP002954302 [A] * the whole document * DOI: http://dx.doi.org/10.1038/nbt0202-149 | [T] - PASCHEN A ET AL., "Use of HLA transgenic mice and predictive algorithms for the identification of a new HLA-DR3 restricted epitope from the TRP2 (Tyrosinase related protein 2) melanoma differentiation antigen", ARCHIVES OF DERMATOLOGICAL RESEARCH, (200402), vol. 295, no. 8-9, page 340, XP008035081 [T] * page P039 * |